IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Nevada

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Nevada  $ 3,068,649.00
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
AKI Bioscience, Incorporated NATRIUTRETIC PEPTIDE RECEPTOR AGONISTS FOR THE TREATMENT OF HEART FAILURE AND HYPERTENSION $ 31,903.50 $ 30,000.00
CardioVascular BioTherapeutics Inc Human FGF1 (CVBT-141C) to Treat Peripheral Artery Disease   $ 40,365.00
CardioVascular BioTherapeutics Inc Human FGF-1 (CVBT-141A) to Treat Coronary Heart Disease $ 244,479.25  
Deuteria Pharmaceuticals, LLC Scale-up of tetradeuterio p-flurobenzaldehyde $ 18,921.50 $ 148,647.50
Deuteria Pharmaceuticals, LLC Deuterium-enriched atorvastatin Derivatives $ 12,500.00  
Deuteria Pharmaceuticals, LLC Deuterium-enriched oxybutynin derivatives $ 51,420.00 $ 110,750.00
LANCO Biosciences Inc Neridronate   $ 244,479.25
NEXGEN MEDICAL SYSTEMS, INC DEVICES FOR THERAPEUTIC DRUG DELIVERY TO BRAIN TUMORS $ 45,851.00 $ 34,506.50
NexGen Medical Systems, Inc Devices for Therapeutic Drug Delivery $ 91,562.50 $ 67,512.50
NexGen Medical Systems, Inc Devices for Blood Clot Removal $ 228,906.00 $ 15,573.25
PEMF SYSTEMS INC Development of a Pulsed Electro-Magnetic Field generator to treat Osteoarthritis   $ 196,000.00
Redlabs, U.S.A. Inc. Sandwhich ELISA for XMRV Detection   $ 232,875.00
Samaritan Pharmaceuticals, Inc. SP-233, A New and Novel Mechanism of Action for the Treatment of Alzheimer Disease   $ 244,479.25
Samaritan Pharmaceuticals, Inc. SP1000, A Novel Therapy for the Removal of Excessive Cholesterol Directly from the Blood   $ 244,479.25
Samaritan Pharmaceuticals, Inc. SP-6310, As a Treatment of HIV-infected Patients with Abnormal Cortisol Levels   $ 244,479.25
Sierra Sciences, LLC hTERt $ 244,479.25  
Soar BioDynamics Inc. Early Detection of High-Risk Prostate Cancer Project $ 244,479.25  

Rate the Small Business and Self-Employed Website

Page Last Reviewed or Updated: 17-Oct-2014